SCHEMBL5984429

SCHEMBL5984429

[CH2]CCC=CCCCCCCCCCCCCCCC[CH2]

nearest known ligand 0.35

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
FAAH O00519 4/20 0.35
TRPV1 Q8NER1 1/20 0.35
TERT O14746 3/20 0.30
PTPN1 P18031 3/20 0.30
PPARG P37231 3/20 0.30
PPARD Q03181 3/20 0.30
PPARA Q07869 3/20 0.30
CYP1A2 P05177 2/20 0.30
MAPT P10636 2/20 0.30
CYP2C19 P33261 2/20 0.30
BLM P54132 2/20 0.30
HSD17B10 Q99714 2/20 0.30
FABP4 P15090 2/20 0.30
F7 P08709 2/20 0.30
F3 P13726 2/20 0.30
KMT2A Q03164 2/20 0.30
GMNN O75496 1/20 0.30
USP2 O75604 1/20 0.30
LMNA P02545 1/20 0.30
POLB P06746 1/20 0.30

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL5985900 1.00 FAAH (0.35) FAAHTRPV1TERTPTPN1PPARG
SCHEMBL5985434 1.00 FAAH (0.35) FAAHTRPV1TERTPTPN1PPARG
SCHEMBL3209946 1.00 FAAH (0.35) FAAHTRPV1TERTPTPN1PPARG
SCHEMBL5986526 1.00 FAAH (0.35) FAAHTRPV1TERTPTPN1PPARG
SCHEMBL5985772 1.00 FAAH (0.35) FAAHTRPV1TERTPTPN1PPARG
SCHEMBL5984821 1.00 FAAH (0.35) FAAHTRPV1TERTPTPN1PPARG
SCHEMBL5985438 1.00 FAAH (0.35) FAAHTRPV1TERTPTPN1PPARG
SCHEMBL5984319 1.00 FAAH (0.35) FAAHTRPV1TERTPTPN1PPARG
SCHEMBL5984984 1.00 FAAH (0.35) FAAHTRPV1TERTPTPN1PPARG
SCHEMBL5984535 1.00 FAAH (0.35) FAAHTRPV1TERTPTPN1PPARG

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-7018993-B2 Antiandrogenic agent CHUGAI SEIYAKU KABUSHIKI KAISHA (JP) 2006-03-28 US disclosed
US-20030158164-A1 Novel antiandrogenic agent CHUGAI SEIYAKU KABUSHIKI KAISHA (JP) 2003-08-21 US disclosed
EP-1304334-A1 NOVEL ANTIANDROGENIC AGENT CHUGAI SEIYAKU KABUSHIKI KAISHA (JP) 2003-04-23 EP disclosed
EP-1219631-A1 ANTIANDROGEN AGENTS CHUGAI SEIYAKU KABUSHIKI KAISHA (JP) 2002-07-03 EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20030158164-A1 Novel antiandrogenic agent NR5A1, CYP19A1, HSD17B11 FAAH 1409/4885TRPV1 4436/4885TERT 3575/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.